164 related articles for article (PubMed ID: 2653425)
21. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.
Kawasaki T; Taniuchi Y; Hisamichi N; Fujimura Y; Suzuki M; Titani K; Sakai Y; Kaku S; Satoh N; Takenaka T
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):947-53. PubMed ID: 8948455
[TBL] [Abstract][Full Text] [Related]
22. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
23. Multiple epitope specificity of monoclonal antibodies to a single synthetic peptide: use in the characterization of the GP IIb-IIIa binding domain of von Willebrand factor.
Berliner SA; Houghten RA; Roberts JR; Ruggeri ZM
Adv Exp Med Biol; 1990; 281():133-44. PubMed ID: 1715119
[TBL] [Abstract][Full Text] [Related]
24. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
Gralnick HR; Williams SB; Coller BS
Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859
[TBL] [Abstract][Full Text] [Related]
26. Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa.
Ando B; Wiedmer T; Hamilton KK; Sims PJ
J Biol Chem; 1988 Aug; 263(24):11907-14. PubMed ID: 3261296
[TBL] [Abstract][Full Text] [Related]
27. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.
Deckmyn H; Stanssens P; Hoet B; Declerck PJ; Lauwereys M; Gansemans Y; Tornai I; Vermylen J
Br J Haematol; 1994 Jul; 87(3):562-71. PubMed ID: 7993797
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
29. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
[TBL] [Abstract][Full Text] [Related]
30. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
[TBL] [Abstract][Full Text] [Related]
31. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.
Beacham DA; Wise RJ; Turci SM; Handin RI
J Biol Chem; 1992 Feb; 267(5):3409-15. PubMed ID: 1737795
[TBL] [Abstract][Full Text] [Related]
32. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
[TBL] [Abstract][Full Text] [Related]
33. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis.
Liu CZ; Peng HC; Huang TF
Toxicon; 1995 Oct; 33(10):1289-98. PubMed ID: 8599180
[TBL] [Abstract][Full Text] [Related]
34. Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4.
McGregor JL; McGregor L; Bauer AS; Catimel B; Brochier J; Dechavanne M; Clemetson KJ
Eur J Biochem; 1986 Sep; 159(3):443-9. PubMed ID: 2944746
[TBL] [Abstract][Full Text] [Related]
35. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
36. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
[TBL] [Abstract][Full Text] [Related]
37. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding.
Peerschke EI
Blood; 1992 Feb; 79(4):948-53. PubMed ID: 1737104
[TBL] [Abstract][Full Text] [Related]
38. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
[TBL] [Abstract][Full Text] [Related]
39. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.
Piétu G; Ribba AS; Chérel G; Meyer D
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911
[TBL] [Abstract][Full Text] [Related]
40. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
